P

Inventor

FREIER SUSAN M

US255 patents
⚠️ This page may combine multiple inventors who share the name “FREIER SUSAN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ISIS PHARMACEUTICALS INC

26 patents
US7399853B2Jul 15, 2008

Modulation of glucagon receptor expression

ISIS PHARMACEUTICALS INC105 citations99
US7217572B2May 15, 2007

Modulation of HIF1α and HIF2α expression

ISIS PHARMACEUTICALS INC139 citations99
US5576208ANov 19, 1996

Antisense oligonucleotide inhibition of the RAS gene

ISIS PHARMACEUTICALS INC151 citations99
US7951934B2May 31, 2011

Compositions and their uses directed to huntingtin

ISIS PHARMACEUTICALS INC51 citations98
US7563884B2Jul 21, 2009

Antisense modulation of PTP1B expression

ISIS PHARMACEUTICALS INC67 citations98
US7339051B2Mar 4, 2008

Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)

ISIS PHARMACEUTICALS INC158 citations98
US7235653B2Jun 26, 2007

Oligonucleotide compositions and methods for the modulation of the expression of B7 protein

ISIS PHARMACEUTICALS INC117 citations98
US6383808B1May 7, 2002

Antisense inhibition of clusterin expression

ISIS PHARMACEUTICALS INC99 citations98
US6287860B1Sep 11, 2001

Antisense inhibition of MEKK2 expression

ISIS PHARMACEUTICALS INC334 citations98
US6210892B1Apr 3, 2001

Alteration of cellular behavior by antisense modulation of mRNA processing

ISIS PHARMACEUTICALS INC358 citations98
US9057066B2Jun 16, 2015

Compositions and their uses directed to huntingtin

ISIS PHARMACEUTICALS INC37 citations97
US8952145B2Feb 10, 2015

Compositions and their uses directed to huntingtin

ISIS PHARMACEUTICALS INC23 citations96
US7902163B2Mar 8, 2011

Antisense modulation of superoxide dismutase 1, soluble expression

ISIS PHARMACEUTICALS INC34 citations96
US7803930B2Sep 28, 2010

Antisense modulation of apolipoprotein B-expression

ISIS PHARMACEUTICALS INC40 citations96
US7678895B2Mar 16, 2010

Antisense modulation of superoxide dismutase 1, soluble expression

ISIS PHARMACEUTICALS INC28 citations96
US7622455B2Nov 24, 2009

Methods for slowing familial ALS disease progression

ISIS PHARMACEUTICALS INC42 citations96
US7321828B2Jan 22, 2008

System of components for preparing oligonucleotides

ISIS PHARMACEUTICALS INC216 citations96
US6455308B1Sep 24, 2002

Antisense modulation of serum amyloid A4 expression

ISIS PHARMACEUTICALS INC69 citations96
US6359124B1Mar 19, 2002

Antisense inhibition of ras gene with chimeric and alternating oligonucleotides

ISIS PHARMACEUTICALS INC67 citations96
US5965722AOct 12, 1999

Antisense inhibition of ras gene with chimeric and alternating oligonucleotides

ISIS PHARMACEUTICALS INC53 citations96
US5837449ANov 17, 1998

Compositions and methods for modulating β-amyloid

ISIS PHARMACEUTICALS INC68 citations96
US5582986ADec 10, 1996

Antisense oligonucleotide inhibition of the ras gene

ISIS PHARMACEUTICALS INC75 citations96
US9765338B2Sep 19, 2017

Modulation of dystrophia myotonica-protein kinase (DMPK) expression

ISIS PHARMACEUTICALS INC67 citations95
US7176303B2Feb 13, 2007

Modulation of STAT5 expression

ISIS PHARMACEUTICALS INC42 citations95
US9382540B2Jul 5, 2016

Compositions and methods for modulating angiopoietin-like 3 expression

ISIS PHARMACEUTICALS INC13 citations93
US9061044B2Jun 23, 2015

Modulation of transthyretin expression

ISIS PHARMACEUTICALS INC14 citations93

BENNETT C FRANK

10 patents

IONIS PHARMACEUTICALS INC

7 patents

REGULUS THERAPEUTICS INC

2 patents

FREIER SUSAN M

2 patents

SWAYZE ERIC E

1 patent

GENZYME CORP

1 patent

LOLLO BRIDGET

1 patent

Showing the top 50 of 255 patents by PatentIndex Score.